HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal toxicity in rats following in utero exposure to chlorphentermine or phentermine.

Abstract
The administration of chlorphentermine (30 mg/kg) to pregnant rats during the last 5 days of gestation resulted in the development of a phospholipidosis in the lungs of the dams. The disorder developed in utero, as the phospholipidosis was evident in the lungs of the neonates when examined at 12 h postpartum. In contrast, a phospholipidosis was not observed in the lungs of the dams or neonates following phentermine treatment (30 mg/kg). Concurrently, neonates of the chlorphentermine-treated dams displayed a significant decrease in body weight in comparison to controls. Between 16 h and 24 h postpartum, 83% of the neonates of chlorphentermine-treated dams died. Cross-fostering and starvation experiments revealed that the lethality was not due to aberrant maternal behavior by the chlorphentermine-treated dams or malnutrition of the neonates. Histological examinations revealed endothelial and septal alterations in the lungs of neonates from chlorphentermine-treated dams. No signs of toxicity, as evidenced by the maintenance of body weight, or lethality were observed in the neonates of the phentermine-treated dams.
AuthorsD Thoma-Laurie, E R Walker, M J Reasor
JournalToxicology (Toxicology) Vol. 24 Issue 1 Pg. 85-94 ( 1982) ISSN: 0300-483X [Print] Ireland
PMID7135406 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Phospholipids
  • Phentermine
  • Chlorphentermine
Topics
  • Animals
  • Animals, Newborn (physiology)
  • Body Weight (drug effects)
  • Chlorphentermine (toxicity)
  • Female
  • Lung (pathology)
  • Lung Diseases (chemically induced, metabolism)
  • Maternal-Fetal Exchange
  • Phentermine (analogs & derivatives, toxicity)
  • Phospholipids (metabolism)
  • Pregnancy
  • Rats
  • Starvation (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: